Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
58
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues48
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy41
40
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease31
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life30
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice29
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature28
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population27
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards27
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies26
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis25
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases25
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants25
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years24
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies24
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method24
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment24
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More24
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease23
Arterial Thrombosis in Cancer Patients: An Update23
Testing for Lupus Anticoagulants23
Platelet Activation and Thrombosis in COVID-1922
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient21
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice21
Platelet Function Testing: Update and Future Directions21
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L19
Editorial Compilation—XIII19
Fifty Years of Fibrinogen Structure and Function19
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives19
Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis17
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey17
The History of Rare Bleeding Disorders17
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings16
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review15
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues15
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future15
Cardiovascular Mortality after Venous Thromboembolism: A Meta-Analysis of Prospective Cohort Studies15
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism15
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase14
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles14
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III14
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment14
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review14
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System14
Toward 50 Years of Seminars in Thrombosis and Hemostasis14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management13
13
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment13
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories13
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu12
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics12
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance12
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans12
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review12
12
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale12
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data12
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency11
11
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?11
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer11
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities11
Automation in Platelet Function Testing: Current Challenges and Future Directions11
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic11
Why “the Love of Blood” in Hemophilia?11
Editorial Compilation XIV10
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials10
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives10
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis10
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy10
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis10
Colchicine as a Modulator of Platelet Function: A Systematic Review10
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls10
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome10
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?10
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review10
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review10
Venous Thromboembolism in Children: The Rivaroxaban Experience10
A Historical Perspective on the Reversal of Anticoagulants10
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia10
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications9
9
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art9
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions9
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature9
Editorial Compilation XI9
Bleeding Scoring Systems in Neonates: A Systematic Review9
Precision Medicine in Rare Bleeding Disorders9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice9
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass9
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis9
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)9
9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles9
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review8
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure8
Non-factor Therapies for Hemophilia: Achievements and Perspectives8
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines8
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?8
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations8
Hemostasis Testing in the Emergency Department: A Narrative Review8
The Role of Platelets in Atherosclerosis: A Historical Review8
Thrombin Generation Assays: What are the Current Clinical Applications?8
Platelet Physiology8
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism8
NETosis in Acute Thrombotic Disorders8
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke7
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives7
Next-Generation Sequencing and Emerging Technologies*7
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?7
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost7
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?7
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond7
PFA-100 System: A New Method for Assessment of Platelet Dysfunction7
7
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care7
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment7
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards7
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality7
Evolution of Antiphospholipid Syndrome7
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies7
Crucial Stepping Stones in Platelet History6
Antiplatelet Therapy in Coronary Artery Disease: Now and Then6
Clinical, Laboratory Aspects and Management of Factor X Deficiency6
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments6
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency6
6
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-196
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessmen6
6
Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review6
Welcome to Seminars in Thrombosis & Hemostasis 20226
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study6
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research6
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 50006
Internal Quality Control in Hemostasis Assays6
The More Recent History of Hemophilia Treatment6
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation6
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer6
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics6
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation6
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up6
One Hundred Years of Congenital Fibrinogen Disorders6
0.078253984451294